Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation of Antidepressant Properties of Yohimbine by Employing Structure-Based Computational Assessments.

Current issues in molecular biology - 27 Oct 2021

Tasleem Munazzah, Alrehaily Abdulwahed, Almeleebia Tahani M, Alshahrani Mohammad Y, Ahmad Irfan, Asiri Mohammed, Alabdallah Nadiyah M, Saeed Mohd

Abstract excerpt

The use of pharmaceuticals to treat Major Depressive Disorder (MDD) has several drawbacks, including severe side effects. Natural compounds with great efficacy and few side effects are in high demand due to the global rise in MDD and ineffective treatment. Yohimbine, a natural compound, has been used to treat various ailments, including neurological conditions, since ancient times. Serotonergic neurotransmission...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Protein Conformation
Share to Antidepressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood-Brain Barrier

Share to Molecular Conformation

Share to Molecular Structure

Share to Permeability

Share to Receptor, Serotonin, 5-HT1A

Share to Structure-Activity Relationship

Source

Open in PubMed Open full text

Identifiers

PMID: 34889886
DOI: 10.3390/cimb43030127
PMCID: PMC8929124

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation of Antidepressant Properties of Yohimbine by Employing Structure-Based Computational Assessments.PMID 34889886Read ↗

Comparative Molecular Docking and Toxicity Profiling of Buspirone and Tandospirone Targeting the HTR1A ReceptorSemantic proximity Read ↗

The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.Semantic proximity Read ↗

Structural basis for recognition of diverse antidepressants by the human serotonin transporter.Semantic proximity Read ↗

Computational Design of Two New 5-HT <sub>1</sub> B Serotonin Receptor Agonists Derived from NaratriptanSemantic proximity Read ↗

Homology modeling and Structural docking analysis on a human BDNF gene by using Computational algorithmsSemantic proximity Read ↗

Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel.Semantic proximity Read ↗

Structural basis for recognition of diverse antidepressants by the human serotonin transporterSemantic proximity Read ↗

Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT <sub>1F</sub> –G protein complexSemantic proximity Read ↗

Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2AR) modulatorsSemantic proximity Read ↗

Identification of novel Plasmodium falciparum dihydroorotate dehydrogenase inhibitors for malaria using in silico studiesSemantic proximity Read ↗

Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs.Semantic proximity Read ↗

Development of a novel peripherally acting alpha2A-adrenergic receptor antagonist for anti-diabeticSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.